293 related articles for article (PubMed ID: 19168602)
41. A reassessment of the plateauing relationship between T2 lesion load and disability in MS.
Sormani MP; Rovaris M; Comi G; Filippi M
Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123
[TBL] [Abstract][Full Text] [Related]
42. Early detection of behavioral side effects of antiepileptic treatment using handheld computers.
Frings L; Wagner K; Maiwald T; Carius A; Schinkel A; Lehmann C; Schulze-Bonhage A
Epilepsy Behav; 2008 Aug; 13(2):402-6. PubMed ID: 18539084
[TBL] [Abstract][Full Text] [Related]
43. Effects of levetiracetam as an add-on therapy on cognitive function and quality of life in patients with refractory partial seizures.
Zhou B; Zhang Q; Tian L; Xiao J; Stefan H; Zhou D
Epilepsy Behav; 2008 Feb; 12(2):305-10. PubMed ID: 18024209
[TBL] [Abstract][Full Text] [Related]
44. The effect of changed visual feedback on intention tremor in multiple sclerosis.
Feys P; Helsen W; Buekers M; Ceux T; Heremans E; Nuttin B; Ketelaer P; Liu X
Neurosci Lett; 2006 Feb; 394(1):17-21. PubMed ID: 16257487
[TBL] [Abstract][Full Text] [Related]
45. Clinical, cognitive, and neurophysiologic correlates of short-term treatment with carbamazepine, oxcarbazepine, and levetiracetam in healthy volunteers.
Mecarelli O; Vicenzini E; Pulitano P; Vanacore N; Romolo FS; Di Piero V; Lenzi GL; Accornero N
Ann Pharmacother; 2004 Nov; 38(11):1816-22. PubMed ID: 15367726
[TBL] [Abstract][Full Text] [Related]
46. Comparison of the effect of two types of acupuncture on quality of life in secondary progressive multiple sclerosis: a preliminary single-blind randomized controlled trial.
Donnellan CP; Shanley J
Clin Rehabil; 2008 Mar; 22(3):195-205. PubMed ID: 18285429
[TBL] [Abstract][Full Text] [Related]
47. The efficacy of primidone in reducing severe cerebellar tremors in patients with multiple sclerosis.
Naderi F; Javadi SA; Motamedi M; Sahraian MA
Clin Neuropharmacol; 2012; 35(5):224-6. PubMed ID: 22821064
[TBL] [Abstract][Full Text] [Related]
48. Comparison of the effects of acetyl L-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial.
Tomassini V; Pozzilli C; Onesti E; Pasqualetti P; Marinelli F; Pisani A; Fieschi C
J Neurol Sci; 2004 Mar; 218(1-2):103-8. PubMed ID: 14759641
[TBL] [Abstract][Full Text] [Related]
49. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy.
Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML
Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647
[TBL] [Abstract][Full Text] [Related]
50. Dose-response population analysis of levetiracetam add-on treatment in refractory epileptic patients with partial onset seizures.
Snoeck E; Stockis A
Epilepsy Res; 2007 Mar; 73(3):284-91. PubMed ID: 17196793
[TBL] [Abstract][Full Text] [Related]
51. Carisbamate in essential tremor: brief report of a proof of concept study.
Elble RJ; Biondi DM; Ascher S; Wiegand F; Hulihan J
Mov Disord; 2010 Apr; 25(5):634-8. PubMed ID: 20201005
[TBL] [Abstract][Full Text] [Related]
52. Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.
Balcer LJ; Galetta SL; Calabresi PA; Confavreux C; Giovannoni G; Havrdova E; Hutchinson M; Kappos L; Lublin FD; Miller DH; O'Connor PW; Phillips JT; Polman CH; Radue EW; Rudick RA; Stuart WH; Wajgt A; Weinstock-Guttman B; Wynn DR; Lynn F; Panzara MA
Neurology; 2007 Apr; 68(16):1299-304. PubMed ID: 17438220
[TBL] [Abstract][Full Text] [Related]
53. Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study.
Striano P; Coppola A; Vacca G; Zara F; Brescia Morra V; Orefice G; Striano S
J Neurol; 2006 Jun; 253(6):762-6. PubMed ID: 16683063
[TBL] [Abstract][Full Text] [Related]
54. The effect of cannabis on tremor in patients with multiple sclerosis.
Fox P; Bain PG; Glickman S; Carroll C; Zajicek J
Neurology; 2004 Apr; 62(7):1105-9. PubMed ID: 15079008
[TBL] [Abstract][Full Text] [Related]
55. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
Rabkin JG; Gordon PH; McElhiney M; Rabkin R; Chew S; Mitsumoto H
Muscle Nerve; 2009 Mar; 39(3):297-303. PubMed ID: 19208404
[TBL] [Abstract][Full Text] [Related]
56. Unsteady gaze fixation enhances the severity of MS intention tremor.
Feys P; Helsen W; Nuttin B; Lavrysen A; Ketelaer P; Swinnen S; Liu X
Neurology; 2008 Jan; 70(2):106-13. PubMed ID: 18180440
[TBL] [Abstract][Full Text] [Related]
57. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
58. Effect of levetiracetam on depression and anxiety in adult epileptic patients.
Mazza M; Martini A; Scoppetta M; Mazza S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):539-43. PubMed ID: 18031881
[TBL] [Abstract][Full Text] [Related]
59. Association between MRI parameters and the MS severity scale: a 12 year follow-up study.
Minneboo A; Uitdehaag BM; Jongen P; Vrenken H; Knol Dl; van Walderveen MA; Polman CH; Castelijns JA; Barkhof F
Mult Scler; 2009 May; 15(5):632-7. PubMed ID: 19389751
[TBL] [Abstract][Full Text] [Related]
60. Efficacy and safety of lacosamide in diabetic neuropathic pain: an 18-week double-blind placebo-controlled trial of fixed-dose regimens.
Wymer JP; Simpson J; Sen D; Bongardt S;
Clin J Pain; 2009 Jun; 25(5):376-85. PubMed ID: 19454870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]